$AMRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Amneal Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Amneal Pharmaceuticals, Inc.. Get notifications about new insider transactions in Amneal Pharmaceuticals, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 11 2021 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | Executive Vice Pres ... | Option Exercise | M | 0.00 | 4,441 | 0 | 4,442 | |
May 11 2021 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | Executive Vice Pres ... | Payment of Exercise | F | 5.20 | 1,562 | 8,122 | 282,819 | 284.4 K to 282.8 K (-0.55 %) |
May 11 2021 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | Executive Vice Pres ... | Buy | M | 0.00 | 4,441 | 0 | 284,381 | 279.9 K to 284.4 K (+1.59 %) |
May 11 2021 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | Executive Vice Pres ... | Option Exercise | M | 0.00 | 4,441 | 0 | 4,442 | |
May 11 2021 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | Executive Vice Pres ... | Payment of Exercise | F | 5.20 | 1,366 | 7,103 | 214,996 | 216.4 K to 215 K (-0.63 %) |
May 11 2021 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | Executive Vice Pres ... | Buy | M | 0.00 | 4,441 | 0 | 216,362 | 211.9 K to 216.4 K (+2.10 %) |
May 11 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Option Exercise | M | 0.00 | 16,655 | 0 | 16,656 | |
May 11 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Payment of Exercise | F | 5.20 | 8,353 | 43,436 | 139,750 | 148.1 K to 139.8 K (-5.64 %) |
May 11 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Buy | M | 0.00 | 16,655 | 0 | 148,103 | 131.4 K to 148.1 K (+12.67 %) |
May 11 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Option Exercise | M | 0.00 | 16,655 | 0 | 16,656 | |
May 11 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Payment of Exercise | F | 5.20 | 8,353 | 43,436 | 139,750 | 148.1 K to 139.8 K (-5.64 %) |
May 11 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Buy | M | 0.00 | 16,655 | 0 | 148,103 | 131.4 K to 148.1 K (+12.67 %) |
May 07 2021 | AMRX | Amneal Pharmaceuti ... | Yanai Shlomo | Director | Option Exercise | M | 0.00 | 46,218 | 0 | 0 | |
May 07 2021 | AMRX | Amneal Pharmaceuti ... | Yanai Shlomo | Director | Option Exercise | A | 0.00 | 35,406 | 0 | 35,406 | |
May 07 2021 | AMRX | Amneal Pharmaceuti ... | Yanai Shlomo | Director | Buy | M | 0.00 | 46,218 | 0 | 53,740 | 7.5 K to 53.7 K (+614.44 %) |
May 07 2021 | AMRX | Amneal Pharmaceuti ... | Alva Emily Peterson | Director | Option Exercise | M | 0.00 | 46,218 | 0 | 0 | |
May 07 2021 | AMRX | Amneal Pharmaceuti ... | Alva Emily Peterson | Director | Option Exercise | A | 0.00 | 35,406 | 0 | 35,406 | |
May 07 2021 | AMRX | Amneal Pharmaceuti ... | Alva Emily Peterson | Director | Buy | M | 0.00 | 46,218 | 0 | 58,784 | 12.6 K to 58.8 K (+367.80 %) |
May 07 2021 | AMRX | Amneal Pharmaceuti ... | Patel Gautam | Director | Option Exercise | M | 0.00 | 46,218 | 0 | 0 | |
May 07 2021 | AMRX | Amneal Pharmaceuti ... | Patel Gautam | Director | Option Exercise | A | 0.00 | 35,406 | 0 | 35,406 | |
May 07 2021 | AMRX | Amneal Pharmaceuti ... | Patel Gautam | Director | Buy | M | 0.00 | 46,218 | 0 | 208,784 | 162.6 K to 208.8 K (+28.43 %) |
May 07 2021 | AMRX | Amneal Pharmaceuti ... | Nark Ted C | Director | Option Exercise | M | 0.00 | 46,218 | 0 | 0 | |
May 07 2021 | AMRX | Amneal Pharmaceuti ... | Nark Ted C | Director | Option Exercise | A | 0.00 | 35,406 | 0 | 35,406 | |
May 07 2021 | AMRX | Amneal Pharmaceuti ... | Nark Ted C | Director | Buy | M | 0.00 | 46,218 | 0 | 108,784 | 62.6 K to 108.8 K (+73.87 %) |
May 07 2021 | AMRX | Amneal Pharmaceuti ... | MEISTER PAUL M | Director | Option Exercise | M | 0.00 | 74,230 | 0 | 0 | |
May 07 2021 | AMRX | Amneal Pharmaceuti ... | MEISTER PAUL M | Director | Option Exercise | A | 0.00 | 52,677 | 0 | 52,677 | |
May 07 2021 | AMRX | Amneal Pharmaceuti ... | MEISTER PAUL M | Director | Buy | M | 0.00 | 74,230 | 0 | 455,802 | 381.6 K to 455.8 K (+19.45 %) |
May 07 2021 | AMRX | Amneal Pharmaceuti ... | Kiely John | Director | Option Exercise | M | 0.00 | 46,218 | 0 | 0 | |
May 07 2021 | AMRX | Amneal Pharmaceuti ... | Kiely John | Director | Option Exercise | A | 0.00 | 35,406 | 0 | 35,406 | |
May 07 2021 | AMRX | Amneal Pharmaceuti ... | Kiely John | Director | Buy | M | 0.00 | 46,218 | 0 | 63,740 | 17.5 K to 63.7 K (+263.77 %) |
May 07 2021 | AMRX | Amneal Pharmaceuti ... | George Jeffrey P. | Director | Option Exercise | M | 0.00 | 46,218 | 0 | 0 | |
May 07 2021 | AMRX | Amneal Pharmaceuti ... | George Jeffrey P. | Director | Option Exercise | A | 0.00 | 35,406 | 0 | 35,406 | |
May 07 2021 | AMRX | Amneal Pharmaceuti ... | George Jeffrey P. | Director | Buy | M | 0.00 | 46,218 | 0 | 77,550 | 31.3 K to 77.6 K (+147.51 %) |
May 07 2021 | AMRX | Amneal Pharmaceuti ... | BUCHI J KEVIN | Director | Option Exercise | M | 0.00 | 46,218 | 0 | 0 | |
May 07 2021 | AMRX | Amneal Pharmaceuti ... | BUCHI J KEVIN | Director | Option Exercise | A | 0.00 | 35,406 | 0 | 35,406 | |
May 07 2021 | AMRX | Amneal Pharmaceuti ... | BUCHI J KEVIN | Director | Buy | M | 0.00 | 46,218 | 0 | 70,085 | 23.9 K to 70.1 K (+193.65 %) |
Mar 17 2021 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | Executive Vice Pres ... | Option Exercise | M | 2.75 | 36,330 | 99,908 | 36,331 | |
Mar 17 2021 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | Executive Vice Pres ... | Sell | S | 6.82 | 36,330 | 247,865 | 279,940 | 316.3 K to 279.9 K (-11.49 %) |
Mar 17 2021 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | Executive Vice Pres ... | Buy | M | 2.75 | 36,330 | 99,908 | 316,270 | 279.9 K to 316.3 K (+12.98 %) |
Mar 17 2021 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | Executive Vice Pres ... | Option Exercise | M | 2.75 | 36,330 | 99,908 | 36,331 | |
Mar 17 2021 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | Executive Vice Pres ... | Sell | S | 6.87 | 36,330 | 249,489 | 211,921 | 248.3 K to 211.9 K (-14.63 %) |
Mar 17 2021 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | Executive Vice Pres ... | Buy | M | 2.75 | 36,330 | 99,908 | 248,251 | 211.9 K to 248.3 K (+17.14 %) |
Mar 15 2021 | AMRX | Amneal Pharmaceuti ... | Konidaris Tasos | Executive Vice Pres ... | Option Exercise | M | 0.00 | 87,719 | 0 | 263,158 | |
Mar 15 2021 | AMRX | Amneal Pharmaceuti ... | Konidaris Tasos | Executive Vice Pres ... | Buy | M | 0.00 | 87,719 | 0 | 87,719 | 0 to 87.7 K |
Mar 03 2021 | AMRX | Amneal Pharmaceuti ... | Patel Chirag K. | President & Co-CEO | Option Exercise | A | 0.00 | 926,640 | 0 | 926,640 | |
Mar 03 2021 | AMRX | Amneal Pharmaceuti ... | Patel Chintu | Co-CEO | Option Exercise | A | 0.00 | 926,640 | 0 | 926,640 | |
Mar 03 2021 | AMRX | Amneal Pharmaceuti ... | Konidaris Tasos | Executive Vice Pres ... | Option Exercise | A | 0.00 | 289,576 | 0 | 289,576 | |
Mar 03 2021 | AMRX | Amneal Pharmaceuti ... | Konidaris Tasos | Executive Vice Pres ... | Option Exercise | A | 0.00 | 144,788 | 0 | 144,788 | |
Mar 03 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Option Exercise | A | 0.00 | 250,966 | 0 | 250,966 | |
Mar 03 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Option Exercise | A | 0.00 | 125,483 | 0 | 125,483 | |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | Executive Vice Pres ... | Option Exercise | M | 0.00 | 11,729 | 0 | 23,457 | |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | Executive Vice Pres ... | Option Exercise | M | 0.00 | 35,620 | 0 | 106,860 | |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | Executive Vice Pres ... | Payment of Exercise | F | 5.18 | 3,607 | 18,684 | 211,921 | 215.5 K to 211.9 K (-1.67 %) |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | Executive Vice Pres ... | Buy | M | 0.00 | 11,729 | 0 | 215,528 | 203.8 K to 215.5 K (+5.76 %) |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | Executive Vice Pres ... | Payment of Exercise | F | 5.39 | 11,548 | 62,244 | 203,799 | 215.3 K to 203.8 K (-5.36 %) |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | Executive Vice Pres ... | Buy | M | 0.00 | 35,620 | 0 | 215,347 | 179.7 K to 215.3 K (+19.82 %) |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | Manzano Stephen | SVP, General Counse ... | Option Exercise | M | 0.00 | 16,490 | 0 | 49,473 | |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | Manzano Stephen | SVP, General Counse ... | Payment of Exercise | F | 5.39 | 5,796 | 31,240 | 10,694 | 16.5 K to 10.7 K (-35.15 %) |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | Manzano Stephen | SVP, General Counse ... | Buy | M | 0.00 | 16,490 | 0 | 16,490 | 0 to 16.5 K |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Option Exercise | M | 0.00 | 12,346 | 0 | 24,692 | |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Option Exercise | M | 0.00 | 31,662 | 0 | 94,987 | |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Payment of Exercise | F | 5.18 | 6,192 | 32,075 | 131,448 | 137.6 K to 131.4 K (-4.50 %) |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Buy | M | 0.00 | 12,346 | 0 | 137,640 | 125.3 K to 137.6 K (+9.85 %) |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Payment of Exercise | F | 5.39 | 16,301 | 87,862 | 125,294 | 141.6 K to 125.3 K (-11.51 %) |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Buy | M | 0.00 | 31,662 | 0 | 141,595 | 109.9 K to 141.6 K (+28.80 %) |
Dec 18 2020 | AMRX | Amneal Pharmaceuti ... | Yanai Shlomo | Director | Option Exercise | M | 0.00 | 7,522 | 0 | 0 | |
Dec 18 2020 | AMRX | Amneal Pharmaceuti ... | Yanai Shlomo | Director | Buy | M | 0.00 | 7,522 | 0 | 7,522 | 0 to 7.5 K |
Dec 18 2020 | AMRX | Amneal Pharmaceuti ... | Kiely John | Director | Option Exercise | M | 0.00 | 7,522 | 0 | 0 | |
Dec 18 2020 | AMRX | Amneal Pharmaceuti ... | Kiely John | Director | Buy | M | 0.00 | 7,522 | 0 | 17,522 | 10 K to 17.5 K (+75.22 %) |
Dec 18 2020 | AMRX | Amneal Pharmaceuti ... | George Jeffrey P. | Director | Option Exercise | M | 0.00 | 7,522 | 0 | 0 | |
Dec 18 2020 | AMRX | Amneal Pharmaceuti ... | George Jeffrey P. | Director | Buy | M | 0.00 | 7,522 | 0 | 31,332 | 23.8 K to 31.3 K (+31.59 %) |
Aug 04 2020 | AMRX | Amneal Pharmaceuti ... | MEISTER PAUL M | Director | Option Exercise | M | 0.00 | 27,923 | 0 | 0 | |
Aug 04 2020 | AMRX | Amneal Pharmaceuti ... | MEISTER PAUL M | Director | Buy | M | 0.00 | 27,923 | 0 | 27,923 | 0 to 27.9 K |
Aug 04 2020 | AMRX | Amneal Pharmaceuti ... | MEISTER PAUL M | Director | Option Exercise | M | 0.00 | 27,923 | 0 | 0 | |
Aug 04 2020 | AMRX | Amneal Pharmaceuti ... | MEISTER PAUL M | Director | Buy | M | 0.00 | 27,923 | 0 | 27,923 | 0 to 27.9 K |
Aug 04 2020 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Option Exercise | A | 0.00 | 69,284 | 0 | 102,595 | |
May 19 2020 | AMRX | Amneal Pharmaceuti ... | Kiely John | Director | Buy | P | 4.40 | 10,000 | 44,000 | 10,000 | 0 to 10 K |
May 15 2020 | AMRX | Amneal Pharmaceuti ... | George Jeffrey P. | Director | Buy | P | 4.16 | 23,810 | 99,050 | 23,810 | 0 to 23.8 K |
May 08 2020 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Option Exercise | M | 0.00 | 16,656 | 0 | 33,311 | |
May 08 2020 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Payment of Exercise | F | 3.55 | 8,353 | 29,653 | 109,933 | 118.3 K to 109.9 K (-7.06 %) |
May 08 2020 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Buy | M | 0.00 | 16,656 | 0 | 118,286 | 101.6 K to 118.3 K (+16.39 %) |
May 08 2020 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | SVP, Chief HR Offic ... | Option Exercise | M | 0.00 | 4,442 | 0 | 8,883 | |
May 08 2020 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | SVP, Chief HR Offic ... | Payment of Exercise | F | 3.55 | 1,326 | 4,707 | 179,727 | 181.1 K to 179.7 K (-0.73 %) |
May 08 2020 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | SVP, Chief HR Offic ... | Buy | M | 0.00 | 4,442 | 0 | 181,053 | 176.6 K to 181.1 K (+2.52 %) |
May 08 2020 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | SVP, Specialty Comm ... | Option Exercise | M | 0.00 | 4,442 | 0 | 8,883 | |
May 08 2020 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | SVP, Specialty Comm ... | Payment of Exercise | F | 3.55 | 2,212 | 7,853 | 254,024 | 256.2 K to 254 K (-0.86 %) |
May 08 2020 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | SVP, Specialty Comm ... | Buy | M | 0.00 | 4,442 | 0 | 256,236 | 251.8 K to 256.2 K (+1.76 %) |
May 08 2020 | AMRX | Amneal Pharmaceuti ... | Patel Chirag K. | President, Co-CEO & ... | Option Exercise | M | 0.00 | 6,459 | 0 | 0 | |
May 08 2020 | AMRX | Amneal Pharmaceuti ... | Patel Chirag K. | President, Co-CEO & ... | Buy | M | 0.00 | 6,459 | 0 | 362,566 | 356.1 K to 362.6 K (+1.81 %) |
May 08 2020 | AMRX | Amneal Pharmaceuti ... | Patel Chintu | Co-CEO and Director | Option Exercise | M | 0.00 | 6,459 | 0 | 0 | |
May 08 2020 | AMRX | Amneal Pharmaceuti ... | Patel Chintu | Co-CEO and Director | Buy | M | 0.00 | 6,459 | 0 | 362,566 | 356.1 K to 362.6 K (+1.81 %) |
May 07 2020 | AMRX | Amneal Pharmaceuti ... | Alva Emily Peterson | Director | Option Exercise | M | 0.00 | 6,459 | 0 | 0 | |
May 07 2020 | AMRX | Amneal Pharmaceuti ... | Alva Emily Peterson | Director | Option Exercise | A | 0.00 | 46,218 | 0 | 46,218 | |
May 07 2020 | AMRX | Amneal Pharmaceuti ... | Alva Emily Peterson | Director | Buy | M | 0.00 | 6,459 | 0 | 12,566 | 6.1 K to 12.6 K (+105.76 %) |
May 07 2020 | AMRX | Amneal Pharmaceuti ... | Nark Ted C | Director | Option Exercise | M | 0.00 | 6,459 | 0 | 0 | |
May 07 2020 | AMRX | Amneal Pharmaceuti ... | Nark Ted C | Director | Option Exercise | A | 0.00 | 46,218 | 0 | 46,218 | |
May 07 2020 | AMRX | Amneal Pharmaceuti ... | Nark Ted C | Director | Buy | M | 0.00 | 6,459 | 0 | 62,566 | 56.1 K to 62.6 K (+11.51 %) |
May 07 2020 | AMRX | Amneal Pharmaceuti ... | Patel Gautam | Director | Option Exercise | M | 0.00 | 6,459 | 0 | 0 | |
May 07 2020 | AMRX | Amneal Pharmaceuti ... | Patel Gautam | Director | Option Exercise | A | 0.00 | 46,218 | 0 | 46,218 | |
May 07 2020 | AMRX | Amneal Pharmaceuti ... | Patel Gautam | Director | Buy | M | 0.00 | 6,459 | 0 | 162,566 | 156.1 K to 162.6 K (+4.14 %) |
May 07 2020 | AMRX | Amneal Pharmaceuti ... | BUCHI J KEVIN | Director | Option Exercise | M | 0.00 | 6,459 | 0 | 0 | |
May 07 2020 | AMRX | Amneal Pharmaceuti ... | BUCHI J KEVIN | Director | Option Exercise | A | 0.00 | 46,218 | 0 | 46,218 | |
May 07 2020 | AMRX | Amneal Pharmaceuti ... | BUCHI J KEVIN | Director | Buy | M | 0.00 | 6,459 | 0 | 23,867 | 17.4 K to 23.9 K (+37.10 %) |
May 06 2020 | AMRX | Amneal Pharmaceuti ... | Yanai Shlomo | Director | Option Exercise | A | 0.00 | 46,218 | 0 | 46,218 | |
May 06 2020 | AMRX | Amneal Pharmaceuti ... | Kiely John | Director | Option Exercise | A | 0.00 | 46,218 | 0 | 46,218 | |
May 06 2020 | AMRX | Amneal Pharmaceuti ... | MEISTER PAUL M | Director | Option Exercise | A | 0.00 | 74,230 | 0 | 74,230 | |
May 06 2020 | AMRX | Amneal Pharmaceuti ... | George Jeffrey P. | Director | Option Exercise | A | 0.00 | 46,218 | 0 | 46,218 | |
May 05 2020 | AMRX | Amneal Pharmaceuti ... | TERRERI PETER R | Director | Option Exercise | M | 0.00 | 6,459 | 0 | 0 | |
May 05 2020 | AMRX | Amneal Pharmaceuti ... | TERRERI PETER R | Director | Buy | M | 0.00 | 6,459 | 0 | 82,758 | 76.3 K to 82.8 K (+8.47 %) |
Mar 19 2020 | AMRX | Amneal Pharmaceuti ... | MEISTER PAUL M | Director | Buy | P | 2.71 | 204,210 | 553,409 | 353,649 | 149.4 K to 353.6 K (+136.65 %) |
Mar 19 2020 | AMRX | Amneal Pharmaceuti ... | MEISTER PAUL M | Director | Buy | P | 2.79 | 149,439 | 416,935 | 149,439 | 0 to 149.4 K |
Mar 16 2020 | AMRX | Amneal Pharmaceuti ... | Konidaris Tasos | SVP and CFO | Option Exercise | A | 0.00 | 701,754 | 0 | 701,754 | |
Mar 16 2020 | AMRX | Amneal Pharmaceuti ... | Konidaris Tasos | SVP and CFO | Option Exercise | A | 0.00 | 350,877 | 0 | 350,877 | |
Mar 11 2020 | AMRX | Amneal Pharmaceuti ... | Patel Chintu | Co-CEO and Director | Buy | P | 3.09 | 100,000 | 309,000 | 356,107 | 256.1 K to 356.1 K (+39.05 %) |
Mar 11 2020 | AMRX | Amneal Pharmaceuti ... | Patel Chirag K. | President, Co-CEO & ... | Buy | P | 3.09 | 100,000 | 309,000 | 356,107 | 256.1 K to 356.1 K (+39.05 %) |
Mar 10 2020 | AMRX | Amneal Pharmaceuti ... | Patel Chirag K. | President, Co-CEO & ... | Buy | P | 3.97 | 58,938 | 233,984 | 256,107 | 197.2 K to 256.1 K (+29.89 %) |
Mar 10 2020 | AMRX | Amneal Pharmaceuti ... | Patel Chirag K. | President, Co-CEO & ... | Buy | P | 3.88 | 156,421 | 606,913 | 197,169 | 40.7 K to 197.2 K (+383.87 %) |
Mar 10 2020 | AMRX | Amneal Pharmaceuti ... | Patel Chirag K. | President, Co-CEO & ... | Buy | P | 3.87 | 34,641 | 134,061 | 40,748 | 6.1 K to 40.7 K (+567.23 %) |
Mar 10 2020 | AMRX | Amneal Pharmaceuti ... | Patel Gautam | Director | Buy | P | 3.94 | 117,889 | 464,483 | 156,107 | 38.2 K to 156.1 K (+308.46 %) |
Mar 10 2020 | AMRX | Amneal Pharmaceuti ... | Patel Gautam | Director | Buy | P | 3.88 | 32,111 | 124,591 | 38,218 | 6.1 K to 38.2 K (+525.81 %) |
Mar 10 2020 | AMRX | Amneal Pharmaceuti ... | Patel Chintu | Co-CEO and Director | Buy | P | 3.97 | 58,765 | 233,297 | 256,107 | 197.3 K to 256.1 K (+29.78 %) |
Mar 10 2020 | AMRX | Amneal Pharmaceuti ... | Patel Chintu | Co-CEO and Director | Buy | P | 3.88 | 156,539 | 607,371 | 197,342 | 40.8 K to 197.3 K (+383.65 %) |
Mar 10 2020 | AMRX | Amneal Pharmaceuti ... | Patel Chintu | Co-CEO and Director | Buy | P | 3.87 | 34,696 | 134,274 | 40,803 | 6.1 K to 40.8 K (+568.13 %) |
Mar 03 2020 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | SVP, Chief HR Offic ... | Option Exercise | M | 0.00 | 11,728 | 0 | 35,186 | |
Mar 03 2020 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | SVP, Chief HR Offic ... | Payment of Exercise | F | 3.85 | 4,228 | 16,278 | 176,611 | 180.8 K to 176.6 K (-2.34 %) |
Mar 03 2020 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | SVP, Chief HR Offic ... | Buy | M | 0.00 | 11,728 | 0 | 180,839 | 169.1 K to 180.8 K (+6.94 %) |
Mar 03 2020 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Option Exercise | M | 0.00 | 12,345 | 0 | 37,038 | |
Mar 03 2020 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Payment of Exercise | F | 3.85 | 6,683 | 25,730 | 101,630 | 108.3 K to 101.6 K (-6.17 %) |
Mar 03 2020 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Buy | M | 0.00 | 12,345 | 0 | 108,313 | 96 K to 108.3 K (+12.86 %) |
Mar 03 2020 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | SVP, Specialty Comm ... | Option Exercise | M | 0.00 | 11,111 | 0 | 33,333 | |
Mar 03 2020 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | SVP, Specialty Comm ... | Payment of Exercise | F | 3.85 | 6,162 | 23,724 | 251,794 | 258 K to 251.8 K (-2.39 %) |
Mar 03 2020 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | SVP, Specialty Comm ... | Buy | M | 0.00 | 11,111 | 0 | 257,956 | 246.8 K to 258 K (+4.50 %) |
Mar 03 2020 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | SVP, Specialty Comm ... | Buy | P | 3.62 | 40,000 | 144,800 | 246,845 | 206.8 K to 246.8 K (+19.34 %) |
Mar 02 2020 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | SVP, Specialty Comm ... | Option Exercise | A | 0.00 | 237,468 | 0 | 237,468 | |
Mar 02 2020 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | SVP, Specialty Comm ... | Option Exercise | A | 0.00 | 118,734 | 0 | 118,734 | |
Mar 02 2020 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | SVP, Chief HR Offic ... | Option Exercise | A | 0.00 | 284,960 | 0 | 284,960 | |
Mar 02 2020 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | SVP, Chief HR Offic ... | Option Exercise | A | 0.00 | 142,480 | 0 | 142,480 | |
Mar 02 2020 | AMRX | Amneal Pharmaceuti ... | Patel Chintu | Co-CEO and Director | Option Exercise | A | 0.00 | 1,266,490 | 0 | 1,266,490 | |
Mar 02 2020 | AMRX | Amneal Pharmaceuti ... | Patel Chirag K. | President, Co-CEO & ... | Option Exercise | A | 0.00 | 1,266,490 | 0 | 1,266,490 | |
Mar 02 2020 | AMRX | Amneal Pharmaceuti ... | Manzano Stephen | SVP, General Counse ... | Option Exercise | A | 0.00 | 131,926 | 0 | 131,926 | |
Mar 02 2020 | AMRX | Amneal Pharmaceuti ... | Manzano Stephen | SVP, General Counse ... | Option Exercise | A | 0.00 | 65,963 | 0 | 65,963 | |
Mar 02 2020 | AMRX | Amneal Pharmaceuti ... | Branning Todd P. | SVP and CFO | Option Exercise | A | 0.00 | 166,226 | 0 | 166,226 | |
Mar 02 2020 | AMRX | Amneal Pharmaceuti ... | Branning Todd P. | SVP and CFO | Option Exercise | A | 0.00 | 83,113 | 0 | 83,113 | |
Mar 02 2020 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Option Exercise | A | 0.00 | 253,298 | 0 | 253,298 | |
Mar 02 2020 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Option Exercise | A | 0.00 | 126,649 | 0 | 126,649 | |
Jan 23 2020 | AMRX | Amneal Pharmaceuti ... | Branning Todd P. | SVP and CFO | Option Exercise | M | 0.00 | 20,096 | 0 | 60,290 | |
Jan 23 2020 | AMRX | Amneal Pharmaceuti ... | Branning Todd P. | SVP and CFO | Payment of Exercise | F | 5.13 | 7,311 | 37,505 | 12,785 | 20.1 K to 12.8 K (-36.38 %) |
Jan 23 2020 | AMRX | Amneal Pharmaceuti ... | Branning Todd P. | SVP and CFO | Buy | M | 0.00 | 20,096 | 0 | 20,096 | 0 to 20.1 K |
Jan 06 2020 | AMRX | Amneal Pharmaceuti ... | BUCHEN DAVID A | SVP, Chief Legal Of ... | Option Exercise | M | 0.00 | 27,614 | 0 | 82,843 | |
Jan 06 2020 | AMRX | Amneal Pharmaceuti ... | BUCHEN DAVID A | SVP, Chief Legal Of ... | Payment of Exercise | F | 4.72 | 8,188 | 38,647 | 20,426 | 28.6 K to 20.4 K (-28.62 %) |